Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    UNITY-NHL
Previous Study | Return to List | Next Study

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02793583
Recruitment Status : Active, not recruiting
First Posted : June 8, 2016
Last Update Posted : January 13, 2022
Information provided by (Responsible Party):
TG Therapeutics, Inc.